Simultaneous Detection of Helicobacter pylori and Clarithromycin Resistance Mutations Using RAA-CRISPR/Cas13a Assay
Kuocheng Yan,Xiaohui Wang,Yao Han,Yuan Tian,Mengwei Niu,Xue Dong,Xiaowei Li,Hao Li,Yansong Sun
DOI: https://doi.org/10.2147/idr.s462963
2024-07-13
Infection and Drug Resistance
Abstract:Kuocheng Yan, 1, &ast Xiaohui Wang, 2, &ast Yao Han, 1, &ast Yuan Tian, 1 Mengwei Niu, 1 Xue Dong, 1 Xiaowei Li, 2 Hao Li, 1 Yansong Sun 1 1 State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, People's Republic of China; 2 Department of Gastroenterology, the Sixth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100080, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hao Li, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, People's Republic of China, Email Xiaowei Li, Department of Gastroenterology, the Sixth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100080, People's Republic of China, Email Background: Infection caused by Helicobacter pylori ( H. pylori ) affects approximately 50% of the global population. It is a major pathogenic factor for chronic gastritis and gastric cancer. Besides, the resistance to antibiotics such as clarithromycin could reduce the eradication rate. Currently, there is an urgent need for a swift, easy to perform, and highly sensitive detection method for H. pylori and clarithromycin resistance. Methods: We used FAM/Digoxin labeled primers to amplify specific H. pylori 23S rRNA fragments by Recombinase Aided Amplification (RAA), and resistance mutations were distinguished using CRISPR/Cas13a system combined with lateral flow strip. Twenty-eight saliva samples were analyzed using qPCR, gene sequencing and this method to evaluate the detection efficiency. Results: We developed a simultaneous detection method for H. pylori and clarithromycin resistance mutations named sensitive H. pylori easy-read dual detection (SHIELD). The results showed both A2142G and A2143G mutant DNAs causing clarithromycin resistance could be distinguished from the wild type with a concentration of 50 copies/μL, and no cross-reaction with other 5 common gastrointestinal bacteria was observed. For the detection of H. pylori in 28 saliva samples, the positive predictive value of this method was 100% (19/19) in comparison with qPCR. For detecting clarithromycin resistance, the positive predictive value of this method was 84.6% (11/13) compared with gene sequencing. Conclusion: SHIELD assay showed high sensitivity and specificity in detecting H. pylori and clarithromycin resistance mutations. It could be a potential measure in the rapid detection of H. pylori , large-scale screening and guiding clinical medication. Keywords: Helicobacter pylori , clarithromycin resistance mutation, recombinase aided amplification, CRISPR/Cas13a, nucleic acid detection Helicobacter pylori ( H. pylori ), a Gram-negative microaerobic flagellated bacterium, impacts a minimum of 50% of the worldwide population based on data from the World Gastrointestinal Organization (WGO). 1 According to a study conducted in China, the prevalence of H. pylori infection among the general population was found to be 40.66%. 2 H. pylori causes chronic gastritis, which can lead to severe gastroduodenal conditions such as peptic ulcers and gastric cancer. 3–5 In addition, H. pylori infection is widely believed to be the primary etiological factor in approximately 90% of gastric cancer cases, 6,7 and the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) have classified it as a class I carcinogen. 8 The initial step towards the treatment and elimination of infections caused by microorganisms is the precise diagnosis. 13/14C-urea breath test (13/14C-UBT) and endoscopic gastric mucosal biopsy are commonly used clinical examination, 4,9 besides, some researchers have developed Quantitative Real-time Polymerase Chain Reaction(qPCR) based techniques for H. pylori detection using saliva or stool specimens. 10,11 However, these methods require skilled practitioners and specialized equipment, making them impractical for grassroots institutions. Fecal antigen detection serves as a representative non-invasive examination, has the advantages of being economical and simple; while its sensitivity remains a limiting factor. 9 To effectively reduce the spread of this disease, there is an urgent need for a rapid, easy-read, and highly sensitive detection approach that can be conveniently employed for pre-hospital detection and m -Abstract Truncated-
pharmacology & pharmacy,infectious diseases